A carregar...
Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab-resistant oral squamous cell carcinoma
High expression of the 110 kDa catalytic subunit of the class IA PI3K (PI3Kp110α) may play an important role in cetuximab resistance exhibited by both colorectal cancer and head and neck squamous cell carcinoma. Therefore, the present study aimed to examine the association between the expression of...
Na minha lista:
| Publicado no: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388413/ https://ncbi.nlm.nih.gov/pubmed/32705230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2020.7674 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|